Clustering of HR+/HER2- breast cancer in an Asian cohort is driven by immune phenotypes
J.-W. Pan, M. E. Ragu, W.-Q. Chan, S. N. Hasan, T. Islan, L.-Y. Teoh, S. Jamaris, M.-H. See, C.-H. Yip, P. Rajadurai, L.-M. Looi, N. A. Mohd Taib, O. M. Rueda, C. Caldas, S.-F. Chin, , S.-H. Teo
This study identifies immune phenotype-driven clustering in HR+/HER2- breast cancer from an Asian cohort, deviating from the luminal A-luminal B classification seen in European populations.
bioRxiv · Dec 7, 2023Cancer Biology